We are live on ! Find out more
BIIB icon

Biogen
BIIB

1,014 hedge funds and large institutions have $59B invested in Biogen in 2017 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 380 increasing their positions, 356 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more funds holding in top 10

Funds holding in top 10: 23 → 38 (+15)

46% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 68

16% more capital invested

Capital invested by funds: $50.9B → $59B (+$8.14B)

2% more funds holding

Funds holding: 992 → 1,014 (+22)

1.38% more ownership

Funds ownership: 87.77% → 89.15% (+1.4%)

7% more repeat investments, than reductions

Existing positions increased: 380 | Existing positions reduced: 356

22% less call options, than puts

Call options by funds: $974M | Put options by funds: $1.24B

Holders
1,014
Holders Change
+22
Holders Change %
+2.22%
% of All Funds
25.28%
Holding in Top 10
38
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+65.22%
% of All Funds
0.95%
New
99
Increased
380
Reduced
356
Closed
68
Calls
$974M
Puts
$1.24B
Net Calls
-$269M
Net Calls Change
-$87M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$513M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$310M
3
Ameriprise
Ameriprise
Minnesota
+$178M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$167M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$133M

Top Sellers

1
BlackRock
BlackRock
New York
-$344M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$206M
3
Renaissance Technologies
Renaissance Technologies
New York
-$190M
4
SIG
Senator Investment Group
New York
-$136M
5
Citadel Advisors
Citadel Advisors
Florida
-$119M
Name Holding Trade Value Shares
Change 		Change in
Stake
HK
551
Horizon Kinetics
New York
$1.45M – – –
GIM
552
Greylin Investment Management
Virginia
$1.44M -$29.6K -100 -2%
P
553
Pitcairn
Pennsylvania
$1.44M -$71.1K -240 -5%
DRS
554
Deane Retirement Strategies
Louisiana
$1.43M -$30.2K -102 -2%
IAS
555
IMA Advisory Services
Colorado
$1.42M +$158K +534 +13%
BFS
556
Bradley Foster & Sargent
Connecticut
$1.42M -$22.8K -77 -2%
MCM
557
MAI Capital Management
Ohio
$1.41M +$42.9K +145 +3%
SCM
558
Stonebridge Capital Management
California
$1.4M -$209K -705 -14%
FC
559
FIC Capital
New York
$1.4M -$67.5K -228 -5%
KIA
560
KCM Investment Advisors
California
$1.4M +$2.96K +10 +0.2%
CTC
561
Central Trust Company
Missouri
$1.38M +$16.3K +55 +1%
LA
562
Lau Associates
Delaware
$1.37M -$14.8K -50 -1%
Fiera Capital (Canada)
563
Fiera Capital (Canada)
Quebec, Canada
$1.35M -$582K -1,964 -31%
AIM
564
ARK Investment Management
Florida
$1.34M +$393K +1,328 +45%
CTA
565
Chesley Taft & Associates
Illinois
$1.33M -$37K -125 -3%
WSCM
566
Wellington Shields Capital Management
New York
$1.32M – – –
PCP
567
Proficio Capital Partners
Massachusetts
$1.32M +$494K +1,669 +65%
HPCM
568
High Pointe Capital Management
Illinois
$1.3M +$11.8K +40 +1%
WCM
569
Wunderlich Capital Managemnt
Tennessee
$1.29M +$1.22M +4,123 New
ECM
570
Everence Capital Management
Indiana
$1.28M – – –
VEA
571
Virtus ETF Advisers
New York
$1.28M – – –
PAMG
572
Patton Albertson Miller Group
Tennessee
$1.26M -$32.6K -110 -3%
AAIM
573
American Assets Investment Management
California
$1.25M – – –
SACTSONJ
574
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
$1.25M – – –
GP
575
GLG Partners
United Kingdom
$1.25M +$1.18M +4,000 New
21 22
23
24 25

BIIB Hedge Fund Activity: Q3 2017 in Review

1,014 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q3 2017, worth a combined $59B — up 16% from $50.9B a quarter earlier.

Buyers outnumbered sellers: 99 funds opened new BIIB positions and 68 closed out — a net gain of 31 holders — while 380 added to existing stakes and 356 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $513M. The largest seller was BlackRock, cutting an estimated $344M.

  • 1,014 institutional investors held Biogen (BIIB) as of Q3 2017, up from 992 in Q2 2017.
  • Funds reported $59B of Biogen stock for Q3 2017, up 16% quarter-over-quarter.
  • 99 funds opened new Biogen positions in Q3 2017 and 68 closed out, a net change of +31 holders.
  • The largest Biogen buyer in Q3 2017 was T. Rowe Price Associates, an estimated $513M added.
  • The largest Biogen seller in Q3 2017 was BlackRock, an estimated $344M sold.

Based on aggregated 13F filings for Q3 2017.